Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.37B | 2.35B | 2.32B | 2.29B | 2.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.37B | 2.35B | 2.32B | 2.29B | 2.25B |
| Cost of Revenue | 1.34B | 1.33B | 1.31B | 1.28B | 1.25B |
| Gross Profit | 1.03B | 1.02B | 1.01B | 1.01B | 999.37M |
| SG&A Expenses | 792.95M | 790.11M | 787.11M | 781.75M | 779.54M |
| Depreciation & Amortization | 18.17M | 18.00M | 17.57M | 17.24M | 17.58M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.15B | 2.14B | 2.11B | 2.08B | 2.05B |
| Operating Income | 217.41M | 209.57M | 208.93M | 209.12M | 202.25M |
| Income Before Tax | 150.19M | 86.22M | 134.64M | 143.60M | 32.14M |
| Income Tax Expenses | 64.81M | 48.05M | 51.94M | 51.80M | 53.39M |
| Earnings from Continuing Operations | 85.39 | 38.16 | 82.70 | 91.80 | -21.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.45M | 5.07M | 233.00K | 180.00K | 658.00K |
| Net Income | 89.84M | 43.23M | 82.93M | 91.98M | -20.59M |
| EBIT | 217.41M | 209.57M | 208.93M | 209.12M | 202.25M |
| EBITDA | 244.10M | 235.61M | 234.15M | 233.57M | 226.54M |
| EPS Basic | 2.74 | 1.32 | 2.54 | 2.82 | -0.64 |
| Normalized Basic EPS | 4.21 | 4.00 | 3.74 | 3.69 | 3.75 |
| EPS Diluted | 2.71 | 1.31 | 2.51 | 2.79 | -0.65 |
| Normalized Diluted EPS | 4.17 | 3.97 | 3.71 | 3.66 | 3.73 |
| Average Basic Shares Outstanding | 131.00M | 130.87M | 130.76M | 130.64M | 130.51M |
| Average Diluted Shares Outstanding | 132.15M | 131.91M | 132.07M | 131.77M | 131.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |